Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
82.39
+0.58 (+0.71%)
Official Closing Price
Updated: 6:30 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
87
88
Next >
What's going on in today's session: S&P500 movers
May 06, 2025
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
May 06, 2025
Via
Benzinga
Why the dividend investor may take a look at MERCK & CO. INC. (NYSE:MRK).
May 06, 2025
Uncovering Dividend Opportunities with MERCK & CO. INC. (NYSE:MRK).
Via
Chartmill
10 Health Care Stocks Whale Activity In Today's Session
May 05, 2025
Via
Benzinga
Merck & Co Unusual Options Activity
May 05, 2025
Via
Benzinga
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
May 03, 2025
Via
The Motley Fool
Topics
Economy
Government
Stocks
8 Health Care Stocks Whale Activity In Today's Session
May 01, 2025
Via
Benzinga
Merck & Co. Inc. (NYSE:MRK): A Potential Undervalued Opportunity
April 30, 2025
Merck & Co. Inc. (NYSE:MRK): A Potential Undervalued Opportunity
Via
Chartmill
Should Investors Buy Merck Stock After These Huge Risks?
April 30, 2025
Via
The Motley Fool
Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now
April 30, 2025
Via
The Motley Fool
Topics
Government
World Trade
How To Put $100 In Your Retirement Fund Each Month With Merck Stock
April 29, 2025
Via
Benzinga
Topics
Retirement
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
April 28, 2025
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
9 Health Care Stocks Whale Activity In Today's Session
April 28, 2025
Via
Benzinga
Why Is Summit Therapeutics Stock Trading Higher On Monday?
April 28, 2025
Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 trial.
Via
Benzinga
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
April 28, 2025
Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for rare tumor treatments and immediate revenue growth.
Via
Benzinga
Despite its impressive fundamentals,MERCK & CO. INC. (NYSE:MRK) remains undervalued.
April 28, 2025
Discover MERCK & CO. INC., an undervalued stock. NYSE:MRK showcases solid financial health and profitability while maintaining an appealing valuation.
Via
Chartmill
Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings
April 28, 2025
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.
Via
StockStory
Topics
Government
World Trade
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
April 26, 2025
Via
The Motley Fool
Topics
Government
World Trade
These S&P500 stocks are moving in today's session
April 25, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...
Via
Chartmill
Merck Stays Confident On M&A Despite Market Uncertainty: Analyst
April 25, 2025
Merck projects $200 million in tariff costs, boosts U.S. manufacturing plans, and continues M&A efforts amid external pressures and shifting market dynamics.
Via
Benzinga
Topics
World Trade
What's Going On With Summit Therapeutics Stock On Friday?
April 25, 2025
Summit Therapeutics' partner Akeso received FDA approval for penpulimab-kcqx in NPC, while ivonescimab showed strong data in lung cancer trials.
Via
Benzinga
Market Monitor April 25 ( Texas Instruments, Nvidia & Amazon UP, IBM, PepsiCo & Comcast DOWN)
April 25, 2025
Wall Street Rallies Again: Tech Leads the Charge, Alphabet Shines After-Hours
Via
Chartmill
Merck (MRK) Q1 2025 Earnings Call Transcript
April 24, 2025
Via
The Motley Fool
Topics
Earnings
World Trade
Halozyme Sues Merck Over Subcutaneous Keytruda Formulation, Seeks Injunctive Relief
April 24, 2025
Halozyme said that it believes the subcutaneous formulation of Merck's cancer medicine Keytruda infringes multiple patents that Halozyme filed beginning in 2011 to protect its groundbreaking MDASE...
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Merck's Q1 Earnings Beat Wall Street, Adjusts 2025 Profit Outlook As Tariffs May Result In Incremental Cost Of $200 Million
April 24, 2025
Merck posted Q1 adjusted EPS of $2.22 and revenue of $15.53 billion, beating estimates while revising full-year guidance amid tariff-related cost pressure.
Via
Benzinga
Topics
Earnings
Merck & Co. Reports Better Than Expected Results For First-Quarter 2025
April 24, 2025
Merck's Q1 2025 results show a slight decrease in total sales but highlight growth in key segments.
Via
Talk Markets
Topics
Stocks / Equities
Durable Goods Orders Jump 9.2% In March, But One Category Tells The Real Story
April 24, 2025
US durable goods orders surged in March, but with a mixed picture. Transportation equipment led the gain, while other sectors showed minimal growth or decline.
Via
Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
April 24, 2025
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...
Via
Benzinga
Topics
Government
World Trade
Merck Reports Strong Q1 Earnings But Downgrades Full-Year Guidance: Retail Sentiment Brightens
April 24, 2025
Merck estimates that the impact of tariffs implemented to date will result in incremental costs of approximately $200 million.
Via
Stocktwits
Topics
Government
World Trade
Merck’s (NYSE:MRK) Q1 Sales Beat Estimates
April 24, 2025
Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue...
Via
StockStory
Topics
Artificial Intelligence
Earnings
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
87
88
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.